N-TERT-BUTYL-4-HYDROXYBENZAMIDE, 95.0%, 500mg

6-(3-Chloropropoxy)-2-(4-(3-chloropropoxy)phenyl)benzo[d]oxazole, 1g

LRRK2-IN-1, 95%, 250mg

D(+)-raffinose pentahydraté, min 98 %, pour la biochimie, 100 g, emballage plastique.

2,1,3-Benzoxadiazole, 97.0%, 1g

5-(3-fluorophenyl)-4H-1,2,4-triazol-3-amine, 95.0%, 100g

6-BROMO-2-CHLOROTHIAZOLO[4,5-B]PYRIDINE, 95.0%, 250mg

2',3'-Didehydro-3'-deoxythymidine>98.0%(HPLC)(T)5g

4-Bromo-2-fluorothiophenol, 95.0%, 5g

(S)-1-(3,5-Difluorophenyl)propan-1-amine hydrochloride, 95%, 250mg

3-Bromo-2,4-difluorobenzaldehyde, 97.0%, 100mg

5-Chloro-1,3-dibromo-2-fluorobenzene, 95%, 5g

5-BROMOOXAZOLE HYDROCHLORIDE, 95%, 1g